Additional EAE studies showed that human CRP's ability to ameliorate disease in CRPtg depends on its ability to engage the inhibitory type IIB Fc gamma receptor (FcγRIIB) [18], a finding which may partially explain the tonic suppressive effect of CRP on T cell-driven autoimmunity [16, 17]. This evidence concerns the gene CRP and Autoimmunity.